0001209191-20-026153.txt : 20200429
0001209191-20-026153.hdr.sgml : 20200429
20200429161441
ACCESSION NUMBER: 0001209191-20-026153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200429
DATE AS OF CHANGE: 20200429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yuchun
CENTRAL INDEX KEY: 0001334365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20830467
MAIL ADDRESS:
STREET 1: 170 TRACER LA.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-28
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001334365
Lee Yuchun
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2020-04-28
4
M
0
1125
57.27
A
3000
D
Common Stock
2020-04-28
4
S
0
200
254.81
D
2800
D
Common Stock
2020-04-28
4
S
0
240
255.79
D
2560
D
Common Stock
2020-04-28
4
S
0
149
257.20
D
2411
D
Common Stock
2020-04-28
4
S
0
120
258.53
D
2291
D
Common Stock
2020-04-28
4
S
0
120
259.61
D
2171
D
Common Stock
2020-04-28
4
S
0
180
260.53
D
1991
D
Common Stock
2020-04-28
4
S
0
116
261.80
D
1875
D
Stock Option (Right to Buy)
57.27
2020-04-28
4
M
0
1125
0.00
D
2022-09-13
Common Stock
1125
0
D
Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $254.81 (range $254.32 to $255.26).
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $255.79 (range $255.40 to $256.14).
Open market sales reported on this line occurred at a weighted average price of $257.20 (range $256.87 to $257.37).
Open market sales reported on this line occurred at a weighted average price of $258.53 (range $258.13 to $258.92).
Open market sales reported on this line occurred at a weighted average price of $259.61 (range $259.28 to $259.94).
Open market sales reported on this line occurred at a weighted average price of $260.53 (range $260.32 to $260.94).
Open market sales reported on this line occurred at a weighted average price of $261.80 (range $261.58 to $262.00).
Fully vested.
/s/ Omar White, Attorney-in-Fact
2020-04-29